Treatment of drug-resistant epilepsy: diet or pill?

Affiliations

¹ Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO 80045, USA. Electronic address: manisha.patel@cuanschutz.edu.

Comment

Manisha Patel. Lancet Neurol. 2023 Dec.

. 2023 Dec;22(12):1088-1089.

doi: 10.1016/S1474-4422(23)00417-9.

¹ Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO 80045, USA. Electronic address: manisha.patel@cuanschutz.edu.

No abstract available

Conflict of interest statement

I declare grants from the US National Institutes of Health and the Dravet Syndrome Foundation, and I am President of the American Epilepsy Society.

Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial.
Schoeler NE, Marston L, Lyons L, Halsall S, Jain R, Titre-Johnson S, Balogun M, Heales SJR, Eaton S, Orford M, Neal E, Reilly C, Eltze C, Stephen E, Mallick AA, O'Callaghan F, Agrawal S, Parker A, Kirkpatrick M, Brunklaus A, McLellan A, McCullagh H, Samanta R, Kneen R, Tan HJ, Devlin A, Prasad M, Rattihalli R, Basu H, Desurkar A, Williams R, Fallon P, Nazareth I, Freemantle N, Cross JH; KIWE study group. Schoeler NE, et al. Lancet Neurol. 2023 Dec;22(12):1113-1124. doi: 10.1016/S1474-4422(23)00370-8. Lancet Neurol. 2023. PMID: 37977712 Clinical Trial.